Not finding it? Sign in to also search OpenAlex live.
-
2022-RA-672-ESGO Comparison of quality of life in patients with platinum-sensitive recurrent ovarian, fallopian tube and peritoneal cancer treated with trabectedin plus pegylated liposomal doxorubicin (PLD) or standard platinum-based therapy: Data look of the NOGGO S16/COMPASS trial2022 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment Open access cited by 1 patent
Radoslav Chekerov, Mustafa Deryal, Bahriye Aktas, Robert Röhle, Annika Stürzebecher, Marco Johannes Battista, +12 more
1citations -
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer2023 Journal for ImmunoTherapy of Cancer article Medicine Ovarian cancer diagnosis and treatment Open access
Els M.E. Verdegaal, Saskia J A M Santegoets, Marij J.P. Welters, Linda de Bruin, Marten Visser, Caroline E. van der Minne, +8 more
30citations -
PO008/#393 Timed adoptive T-cell therapy during chemotherapy in platinum sensitive recurrent epithelial ovarian cancer, the ovacure phase I/II trial2023 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment Open access
Judith R. Kroep, Linda de Bruin, Lien van der Minne, Inge C.F.M. Roozen, Pauline Meij, Sjoerd van der Burg, +1 more
0citations -
Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study
Berbel L.M. Ykema, Tanya M. Bisseling, Manon C.W. Spaander, Leon M.G. Moons, Dorien T. J. van der Biessen‐van Beek, Lisette J. Saveur, +10 more
4citations -
Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy2023 International Journal of Cancer article Medicine Colorectal Cancer Screening and Detection Open access
Emilie C. H. Breekveldt, Berbel L.M. Ykema, Tanya M. Bisseling, Leon M.G. Moons, Manon C.W. Spaander, Inge L. Huibregtse, +19 more
1citations -
Ex vivo tumor testing platform for predicting clinical response to platinum-based therapy in patients with high grade serous ovarian cancer.2023 Journal of Clinical Oncology conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Petronella Beatrix Ottevanger, Judith R. Kroep, Els L. van Persijn-van Meerten, Anne M. van Altena, Cor Doede de Kroon, L. Ceton, +3 more
0citations -
Debio 0123 (zedoresertib), a selective WEE1 inhibitor, in combination with carboplatin in adult patients with platinum-resistant ovarian cancer: Expansion part of the Debio0123-101 phase 1 study.
Arjun Oberoi, Antonio González-Martı́n, Mathilde Jalving, Ignacio Romero, Javier Garciá Corbacho, Ingrid M.E. Desar, +13 more
0citations -
A biophysical study of the interactions of palladium( ii ), platinum( ii ) and gold( iii ) complexes of aminopyridyl-2,2′-bipyridine ligands with RNAs and other nucleic acid structures
Francesca Binacchi, Cassandra Elia, Damiano Cirri, Corjan van de Griend, Xue‐Quan Zhou, Luigi Messori, +3 more
5citations -
LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Susana N. Banerjee, P.B. Ottevanger, Apostolos Sarivalasis, Romuald Le Scodan, Ana Montes, Judith R. Kroep, +9 more
4citations -
1144P Chemo sensitivity score using an ex vivo 3D micro-tumor testing platform to predict clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer
Judith R. Kroep, Cor Doede de Kroon, P.B. Ottevanger, Anne M. van Altena, Timothy J. P. Sijsenaar, Felix M. Behr, +5 more
0citations -
ENGOT-ov62 - reducing chemotherapy duration in high-grade advanced ovarian cancer: A comparison of 3 vs. 6 cycles of platinum-based chemotherapy followed by niraparib maintenance in HRD-positive patients2026 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment Open access
Jalid Sehouli, Eva Roser, Robert Armbrust, Dario Zocholl, Jessica Nguyen, Jessika Goldmann, +10 more
0citations -
356 Personalized immunotherapy by adoptive T cell transfer during chemotherapy with or without interferon-alpha in patients with recurrent platinum-sensitive epithelial ovarian cancer2021 Regular and Young Investigator Award Abstracts conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Els M.E. Verdegaal, Marten Visser, Lien van der Minne, Linda de Bruin, Inge C.F.M. Roozen, Pauline Meij, +2 more
0citations -
Ex vivo 3D micro-tumor testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer.2025 Journal of Clinical Oncology conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Cor Doede de Kroon, Judith R. Kroep, Petronella Beatrix Ottevanger, Anne M. van Altena, Els L. van Persijn van Meerten, L. Ceton, +4 more
0citations -
LBA3 Pembrolizumab vs placebo plus weekly paclitaxel ± bevacizumab in platinum-resistant recurrent ovarian cancer: Results from the randomized double-blind phase III ENGOT-ov65/KEYNOTE-B96 study
N. Colombo, E. Zsiros, Alexandra Sebastianelli, Mariusz Bidziński, Emad Matanes, K. Hasegawa, +12 more
26citations -
PEMBROLIZUMAB VS PLACEBO PLUS PACLITAXEL ± BEVACIZUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: RESULTS FROM THE PHASE 3 ENGOT-OV65/KEYNOTE-B96 STUDY2025 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment
Nicoletta Colombo, Emese Zsíros, Alexandra Sebastianelli, Mariusz Bidziński, Carlos Gallardo, Emad Matanes, +14 more
3citations